Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Lawrence Joseph is active.

Publication


Featured researches published by Lawrence Joseph.


The Journal of Allergy and Clinical Immunology | 2010

A population-based study on peanut, tree nut, fish, shellfish, and sesame allergy prevalence in Canada

Daniel W. Harrington; Lianne Soller; Joseph Fragapane; Lawrence Joseph; Yvan St. Pierre; Samuel Benrejeb Godefroy; Susan J. Elliot; Ann E. Clarke

BACKGROUNDnRecent studies suggest an increased prevalence of food-induced allergy and an increased incidence of food-related anaphylaxis. However, prevalence estimates of food allergies vary considerably between studies.nnnOBJECTIVESnTo determine the prevalence of peanut, tree nut, fish, shellfish, and sesame allergy in Canada.nnnMETHODSnUsing comparable methodology to Sicherer et al in the United States in 2002, we performed a cross-Canada, random telephone survey. Food allergy was defined as perceived (based on self-report), probable (based on convincing history or self-report of physician diagnosis), or confirmed (based on history and evidence of confirmatory tests).nnnRESULTSnOf 10,596 households surveyed in 2008 and 2009, 3666 responded (34.6% participation rate), of which 3613 completed the entire interview, representing 9667 individuals. The prevalence of perceived peanut allergy was 1.00% (95% CI, 0.80%-1.20%); tree nut, 1.22% (95% CI, 1.00%-1.44%); fish, 0.51% (95% CI, 0.37%-0.65%); shellfish, 1.60% (95% CI, 1.35%-1.86%); and sesame, 0.10% (95% CI, 0.04%-0.17%). The prevalence of probable allergy was 0.93% (95% CI, 0.74%-1.12%); 1.14% (95% CI, 0.92%-1.35%); 0.48% (95% CI, 0.34%-0.61%); 1.42% (95% CI, 1.18%-1.66%); and 0.09% (95% CI, 0.03%-0.15%), respectively. Because of the infrequency of confirmatory tests and the difficulty in obtaining results if performed, the prevalence of confirmed allergy was much lower.nnnCONCLUSIONnThis is the first nationwide Canadian study to determine the prevalence of severe food allergies. Our results indicate disparities between perceived and confirmed food allergy that might contribute to the wide range of published prevalence estimates.


The Journal of Allergy and Clinical Immunology | 2012

Overall prevalence of self-reported food allergy in Canada

Lianne Soller; Daniel W. Harrington; Joseph Fragapane; Lawrence Joseph; Yvan St. Pierre; Samuel Benrejeb Godefroy; Sebastien La Vieille; Susan J. Elliott; Ann E. Clarke

Estimate 1: Including all adults Peanut 1.77 (1.21-2.33) 0.78 (0.58-0.97) 1.00 (0.80-1.20) Tree nut 1.73 (1.16-2.30) 1.07 (0.84-1.30) 1.22 (1.00-1.44) Fish 0.18 (0.00-0.36) 0.60 (0.43-0.78) 0.51 (0.37-0.65) Shellfish 0.55 (0.21-0.88) 1.91 (1.60-2.23) 1.60 (1.35-1.86) Sesame 0.23 (0.03-0.43) 0.07 (0.01-0.13) 0.10 (0.04-0.17) Milk 2.23 (1.51-2.95) 1.89 (1.56-2.21) 1.97 (1.64-2.29) Egg 1.23 (0.69-1.77) 0.67 (0.48-0.86) 0.80 (0.61-0.99) Wheat 0.45 (0.08-0.83) 0.86 (0.63-1.08) 0.77 (0.57-0.96) Soy 0.32 (0.08-0.55) 0.16 (0.07-0.25) 0.20 (0.10-0.30) Fruits 1.14 (0.68-1.60) 1.61 (1.32-1.89) 1.50 (1.25-1.75) Vegetables 0.45 (0.17-0.74) 1.29 (1.02-1.55) 1.10 (0.88-1.31) Other 1.32 (0.80-1.84) 1.67 (1.37-1.97) 1.59 (1.32-1.86) All foods 7.14 (5.92-8.36) 8.34 (7.69-8.99) 8.07 (7.47-8.67) Estimate 2: Excluding some adults All foods 7.14 (5.92-8.36) 6.56 (5.99-7.13) 6.69 (6.15-7.24) Estimate 3: Estimate 2 adjusted for nonresponse All foods 7.12 (6.07-8.28) 6.58 (6.22-6.96) 6.67 (6.19-7.17)


Pediatric Allergy and Immunology | 2012

Inadvertent exposures in children with peanut allergy

Nha Uyen Nguyen-Luu; Reza Alizadehfar; Lawrence Joseph; Laurie Harada; Mary Allen; Yvan St-Pierre; Ann E. Clarke

To cite this article: Nguyen‐Luu NU, Ben‐Shoshan M, Alizadehfar R, Joseph L, Harada L, Allen M, St‐Pierre Y, Clarke A. Inadvertent exposures in children with peanut allergy. Pediatr Allergy Immunol 2011: Doi: 10.1111/j.1399‐3038.2011.01235.x


The Journal of Allergy and Clinical Immunology | 2013

Anaphylaxis treated in a Canadian pediatric hospital: Incidence, clinical characteristics, triggers, and management

Sebastian La Vieille; Harley Eisman; Reza Alizadehfar; Christopher Mill; Emma Perkins; Lawrence Joseph; Judy Morris; Ann E. Clarke

University of Medicine and Dentistry of New Jersey, Newark, NJ; and ENT and Allergy Associates, Hoboken, NJ. E-mail: [email protected]. Supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grant 1K23AI103187 (to C.A.K.) and the Eudowood fund. Disclosure of potential conflict of interest: R. A. Wood has consultancy arrangements with the Asthma and Allergy Foundation of America, is employed by Johns Hopkins University, has received one or more grants from or has one or more grants pending with the National Institutes of Health, and has received royalties from UpToDate. The rest of the authors declare that they have no relevant conflicts of interest.


Annals of Allergy Asthma & Immunology | 2008

Availability of the epinephrine autoinjector at school in children with peanut allergy

Rhoda Kagan; Marie-Noël Primeau; Reza Alizadehfar; Nina Verreault; Joyce W. Yu; Nathalie Nicolas; Lawrence Joseph; Elizabeth Turnbull; Claire Dufresne; Yvan St. Pierre; Ann E. Clarke

BACKGROUNDnPeanut allergy accounts for most severe food-related allergic reactions, and accidental exposures are frequent. Delayed administration of epinephrine and the allergic individuals failure to personally carry epinephrine contribute to fatal outcomes.nnnOBJECTIVESnTo describe epinephrine autoinjector availability at school and to determine factors that might affect autoinjector availability in children allergic to peanut.nnnMETHODSnTwo hundred seventy-one children with peanut allergy living in Quebec were queried about their autoinjector. Logistic regression models were used to select factors associated with device availability.nnnRESULTSnFour of 271 children diagnosed as having peanut allergy were not prescribed autoinjectors. Forty-eight percent of the children did not carry the autoinjector with them at school. In 78.0% of those, the autoinjector was located in the nurses or another school office, which was staffed by a full-time nurse only in 18.5%. Of all the respondents, those administered epinephrine for a previous reaction (odds ratio [OR], 2.7; 95% confidence interval [CI], 1.3-5.7), older children (OR, 1.1; 95% CI, 1.0-1.2), and those living only with their mother (OR, 3.4; 95% CI, 1.0-11.0) were more likely to carry the autoinjector with them at school. Of children 7 years or older, those who experienced a severe reaction were more likely to carry their autoinjector (OR, 3.3; 95% CI, 1.4-8.1).nnnCONCLUSIONSnAlmost 50% of children allergic to peanut might experience a delay in anaphylaxis treatment due to limited access to their device. More education is required regarding the importance of a readily available autoinjector.


Archives of Disease in Childhood | 2007

Peanut-free guidelines reduce school lunch peanut contents

D.K. Banerjee; Rhoda Kagan; Elizabeth Turnbull; Lawrence Joseph; Yvan St. Pierre; Claire Dufresne; Katherine Gray-Donald; Ann E. Clarke

Background: Some schools implement peanut-free guidelines (PFG) requesting omission of peanut from lunches. Our study assessed parental awareness of, and adherence to, PFG by comparing the percentage of lunches containing peanut between primary school classes with and without PFG in Montreal, Québec. Methods: Parents, school principals and teachers were queried concerning the school’s PFG and children’s lunches were inspected by a dietician for peanut-containing foods. Results: When lunch peanut contents were compared in randomly selected classrooms, peanut was found in 5/861 lunches in classes with PFG (0.6%, 95% CI 0.2% to 1.4%) and in 84/845 lunches in classes without PFG (9.9%, 95% CI 8.0% to 12.2%), a 9.4% (95% CI 7.3% to 11.4%) difference. Conclusions: Our findings demonstrate that PFG are effective in reducing peanut in classrooms providing a basis for future research that should address whether or not the reduction in peanut achieved by restrictive lunch policies decreases the morbidity associated with peanut allergy in the school setting.


Journal of Allergy | 2012

Demographic predictors of peanut, tree nut, fish, shellfish, and sesame allergy in Canada.

Daniel W. Harrington; Lianne Soller; Joseph Fragapane; Lawrence Joseph; Yvan St. Pierre; Samuel Benrejeb Godefroy; Susan J. Elliott; Ann E. Clarke

Background. Studies suggest that the rising prevalence of food allergy during recent decades may have stabilized. Although genetics undoubtedly contribute to the emergence of food allergy, it is likely that other factors play a crucial role in mediating such short-term changes. Objective. To identify potential demographic predictors of food allergies. Methods. We performed a cross-Canada, random telephone survey. Criteria for food allergy were self-report of convincing symptoms and/or physician diagnosis of allergy. Multivariate logistic regressions were used to assess potential determinants. Results. Of 10,596 households surveyed in 2008/2009, 3666 responded, representing 9667 individuals. Peanut, tree nut, and sesame allergy were more common in children (odds ratio (OR) 2.24 (95% CI, 1.40, 3.59), 1.73 (95% CI, 1.11, 2.68), and 5.63 (95% CI, 1.39, 22.87), resp.) while fish and shellfish allergy were less common in children (OR 0.17 (95% CI, 0.04, 0.72) and 0.29 (95% CI, 0.14, 0.61)). Tree nut and shellfish allergy were less common in males (OR 0.55 (95% CI, 0.36, 0.83) and 0.63 (95% CI, 0.43, 0.91)). Shellfish allergy was more common in urban settings (OR 1.55 (95% CI, 1.04, 2.31)). There was a trend for most food allergies to be more prevalent in the more educated (tree nut OR 1.90 (95% CI, 1.18, 3.04)) and less prevalent in immigrants (shellfish OR 0.49 (95% CI, 0.26, 0.95)), but wide CIs preclude definitive conclusions for most foods. Conclusions. Our results reveal that in addition to age and sex, place of residence, socioeconomic status, and birth place may influence the development of food allergy.


The Journal of Allergy and Clinical Immunology | 2016

Tryptase levels in children presenting with anaphylaxis: Temporal trends and associated factors

Sarah De Schryver; Michelle Halbrich; Ann E. Clarke; Sebastien La Vieille; Harley Eisman; Reza Alizadehfar; Lawrence Joseph; Judy Morris

BACKGROUNDnThe diagnosis of anaphylaxis currently relies on suggestive clinical history after exposure to a potential triggering factor because no reliable diagnostic marker is available to confirm the diagnosis.nnnOBJECTIVESnWe aimed to evaluate tryptase levels in children with anaphylaxis and to examine predictors of elevated tryptase level (defined as ≥11.4 μg/L during reaction and for those with a baseline level, defined as a reaction level of at least 2 ng/mL + 1.2 × [postreaction tryptase level]).nnnMETHODSnChildren presenting with anaphylaxis to the Montreal Childrens Hospital were recruited over a 4-year period. Symptoms, triggers, and management of anaphylaxis were documented. Levels during the reaction and approximately 9 months after the reaction were compared on the basis of paired means using the t distribution. Multivariate linear and logistic regressions were used to evaluate the association between tryptase levels and risk factors.nnnRESULTSnOver a 4-year period, 203 children had serum tryptase levels measured. Among these, 39 children (19.2%; 95% CI, 14.1%-25.4%) had elevated levels. Only severe reactions were associated with reaction levels of 11.4 μg/L or more (odds ratio, 6.5; 95% CI, 2.2-19.0). Milk-induced anaphylaxis and severe reactions were more likely associated with increased tryptase levels (beta-adjusted, 4.0; 95% CI, 0.95-7.0, and 7.5; 95% CI, 4.8-10.3, respectively). Reaction levels exceeding the threshold level of 2 ng/mL + 1.2 × (postreaction tryptase level) detected most of the anaphylactic reactions, particularly if baseline levels were taken within 2 months of the reaction.nnnCONCLUSIONSnTryptase levels are particularly useful for the diagnosis of severe and/or milk-induced anaphylaxis. Assessing the difference between reaction and postreaction tryptase levels may improve diagnostic sensitivity.


The Journal of Allergy and Clinical Immunology: In Practice | 2015

Prevalence and Predictors of Food Allergy in Canada: A Focus on Vulnerable Populations

Lianne Soller; Daniel W. Harrington; Megan Knoll; Joseph Fragapane; Lawrence Joseph; Yvan St. Pierre; Sebastien La Vieille; Kathi Wilson; Susan J. Elliott; Ann E. Clarke

BACKGROUNDnStudies suggest that individuals of low education and/or income, new Canadians (immigrated <10 years ago), and individuals of Aboriginal identity may have fewer food allergies than the general population. However, given the difficulty in recruiting such populations (hereafter referred to as vulnerable populations), by using conventional survey methodologies, the prevalence of food allergy among these populations in Canada has not been estimated.nnnOBJECTIVESnTo estimate the prevalence of food allergy among vulnerable populations in Canada, to compare with the nonvulnerable populations and to identify demographic characteristics predictive of food allergy.nnnMETHODSnBy using 2006 Canadian Census data, postal codes with high proportions of vulnerable populations were identified and households were randomly selected to participate in a telephone survey. Information on food allergies and demographics was collected. Prevalence estimates were weighted by using Census data to account for the targeted sampling. Multivariable logistic regression was used to identify predictors of food allergy.nnnRESULTSnOf 12,762 eligible households contacted, 5734 households completed the questionnaire (45% response rate). Food allergy was less common among adults without postsecondary education versus those with postsecondary education (6.4% [95% CI, 5.5%-7.3%] vs 8.9% [95% CI, 7.7%-10%]) and new Canadians versus those born in Canada (3.2% [95% CI, 2.2%-4.3%] vs 8.2% [95% CI, 7.4%-9.1%]). There was no difference in prevalence between those of low and of high income or those with and without Aboriginal identity.nnnCONCLUSIONnAnalysis of our data suggests that individuals of low education and new Canadians self-report fewer allergies, which may be due to genetics, environment, lack of appropriate health care, or lack of awareness of allergies, which reduces self-report.


International Archives of Allergy and Immunology | 2014

Rate, Triggers, Severity and Management of Anaphylaxis in Adults Treated in a Canadian Emergency Department

Yuka Asai; Yarden Yanishevsky; Ann E. Clarke; Sebastian La Vieille; J. Scott Delaney; Reza Alizadehfar; Lawrence Joseph; Christopher Mill; Judy Morris

Background: The Cross-Canada Anaphylaxis Registry (C-CARE) assesses the triggers and management of anaphylaxis and identifies predictors of the development of severe allergic reactions and of epinephrine use. Here, we present data from an urban adult tertiary care emergency department (ED) in Montreal, Canada. Methods: Potential anaphylaxis cases were identified using ICD-10 codes related to anaphylaxis or allergic reactions. Putative cases underwent chart review to ensure they met anaphylaxis diagnostic criteria. Demographic, clinical and management data were collected. Multivariate logistic regressions were conducted to assess the effect of demographic characteristics, triggers, and comorbidities on severity and management of reactions. Results: Among 37,730 ED visits, 0.26% (95% CI 0.21, 0.32) fulfilled the definition of anaphylaxis. Food was the suspected trigger in almost 60% of cases. Epinephrine was not administered in almost half of moderate-to-severe cases, and similar numbers of individuals with moderate-to-severe reactions were not prescribed an epinephrine autoinjector. Reaction to shellfish was associated with more severe reactions (OR 13.9; 95% CI 2.2, 89.4). Older individuals and those not receiving steroids were more likely managed without epinephrine (OR 1.04; 95% CI 1.01, 1.07 and OR 2.97; 95% CI 1.05, 8.39, respectively). Conclusions: Anaphylaxis accounted for a substantial number of ED visits in adults, and the most common trigger was food. There is non-adherence to guidelines recommending epinephrine use for all cases of anaphylaxis. We postulate that this may be related to concerns regarding the side effects of epinephrine in adults.

Collaboration


Dive into the Lawrence Joseph's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harley Eisman

Montreal Children's Hospital

View shared research outputs
Top Co-Authors

Avatar

Rhoda Kagan

McGill University Health Centre

View shared research outputs
Researchain Logo
Decentralizing Knowledge